ABEO Abeona Therapeutics Inc.

Fundamentals / CIK 0000318306 / USD

Abeona Therapeutics Inc. reported $5.82M in revenue and a net loss of $62.53M for the fiscal year ended December 31, 2025, with a 73.7% gross margin and a -1247.4% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ABEO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$79.13M$39.56M$0-$85.47MFY 2016 Revenue: $889KFY 2016 Net Income: -$21.87M2016FY 2017 Revenue: $837KFY 2017 Net Income: -$27.32M2017FY 2018 Revenue: $3.00MFY 2018 Net Income: -$56.67M2018FY 2019 Net Income: -$76.28M2019FY 2020 Revenue: $10.00MFY 2020 Net Income: -$84.23M2020FY 2021 Revenue: $3.00MFY 2021 Net Income: -$84.94M2021FY 2022 Revenue: $1.41MFY 2022 Net Income: -$39.70M2022FY 2023 Revenue: $3.50MFY 2023 Net Income: -$54.19M2023FY 2024 Net Income: -$63.73M2024FY 2025 Revenue: $5.82MFY 2025 Net Income: $71.18M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $5.82M -- $3.50M $1.41M $3.00M $10.00M -- $3.00M $837K $889K
Cost of Revenue $1.53M -- -- -- -- -- -- -- -- --
Gross Profit $4.29M -- -- -- -- -- -- -- -- --
Research & Development $26.81M $34.36M $31.09M $28.96M $38.73M $30.14M $48.57M $38.70M $16.99M $10.65M
Selling, General & Admin $65.03M $29.85M -- -- -- -- -- -- -- --
Total Operating Expenses -- $64.21M $50.63M $52.33M $92.84M $91.42M $77.09M $61.16M $28.67M --
Operating Income -$89.45M -$64.21M -$47.13M -$50.91M -$89.84M -$81.42M -$77.09M -$58.17M -$27.84M -$23.88M
EBITDA -$86.90M -$62.21M -$44.85M -$47.82M -$86.59M -$76.83M -$69.27M -$55.81M -$27.09M -$23.06M
Interest Income $5.56M $4.25M $2.12M $431K $40K -- -- -- -- --
Interest Expense $3.74M $4.21M $418K $736K $3.66M $4.12M -- -- -- --
Income Before Tax $71.28M -$63.73M -- -- -- -- -- -- -- --
Income Tax Expense $100K -- -- -- -- -- -- $0 $0 $0
Net Income $71.18M -$63.73M -$54.19M -$39.70M -$84.94M -$84.23M -$76.28M -$56.67M -$27.32M -$21.87M
Basic EPS $1.34 -$1.55 -$2.53 -$5.53 -$539.25 -$22.75 -$37.75 -$29.75 -$16.50 -$16.00
Diluted EPS $1.01 -$1.55 -$2.53 -$5.53 -$21.50 -$22.75 -$37.75 -$29.75 -$16.50 -$16.00
Basic Shares Outstanding 53.0M 41.0M 21.4M 7.9M 157.5K 3.7M 2.0M 1.9M 1.7M 1.4M
Diluted Shares Outstanding 66.1M 41.0M 21.4M 7.9M 3.9M 3.7M 2.0M 1.9M 1.7M 1.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $13.49M $11.38M $8.72M -- -- $400K -- --
Cost of Revenue $5.71M $4.18M $2.70M -- $488K -- -- --
Gross Profit $7.78M $7.20M $6.02M -- -- -- -- --
Research & Development $3.67M $5.02M $9.55M $6.71M $4.22M $5.94M $9.94M $8.99M
Selling, General & Admin $17.11M $15.84M $19.50M $18.78M $19.31M $17.15M $9.79M --
Total Operating Expenses -- -- -- -- -- $23.19M $19.73M $16.67M
Operating Income -$13.00M -$13.65M -$23.03M -$22.91M -$24.02M -$22.79M -$19.73M -$16.67M
EBITDA -$12.30M -$12.99M -$22.34M -$22.05M -$23.41M -$22.25M -$19.19M -$16.13M
Interest Income $2.26M $1.35M $1.35M $1.55M $1.67M $1.03M $1.31M $1.02M
Interest Expense $557K $696K $830K $884K $901K $957K $998K $1.08M
Income Before Tax -$4.79M -$20.19M -$17.07M -$20.68M -$20.36M $124.3M -$12.03M --
Income Tax Expense $18K $0 $2.0K -- -$15.20M $15.51M -- --
Net Income -$4.81M -$20.19M -$17.07M -$20.46M -$5.16M $108.8M -$12.03M -$9.29M
Basic EPS -$0.08 -$0.35 -$0.30 -- -$0.10 $2.07 -$0.24 --
Diluted EPS -$0.08 -$0.35 -$0.30 -- -$0.10 $1.71 -$0.24 --
Basic Shares Outstanding 57.9M 57.0M 56.6M -- 54.2M 52.5M 49.8M --
Diluted Shares Outstanding 57.9M 57.0M 56.6M -- 54.2M 66.6M 49.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $78.44M $23.36M $14.47M $14.22M $32.94M $12.60M $129.3M $18.75M $137.8M $69.14M
Short-Term Investments $113.0M $74.36M $37.75M $37.93M $12.09M $82.44M -- $66.22M $0 --
Cash & Short-Term Investments $191.4M $98.10M $52.60M $52.50M $50.90M $95.00M $129.3M $85.00M $137.8M $69.14M
Accounts Receivable, Net $6.15M -- -- -- $3.00M -- -- $81K $107K $124K
Inventory $5.49M -- -- -- -- -- -- -- -- --
Total Current Assets $204.9M $100.9M $55.74M $53.10M $56.29M $97.74M $132.4M $88.85M $140.6M $69.42M
Property, Plant & Equipment, Net $9.92M $4.43M $3.53M $5.74M $12.34M $11.32M $13.16M $9.44M $1.37M $721K
Goodwill -- -- -- -- -- $32.47M $32.47M $32.47M $32.47M $32.47M
Intangible Assets -- -- -- $0 $1.38M $1.50M $36.18M $43.04M $3.98M $8.38M
Other Non-Current Assets $781K $96K $277K $43K $168K -- -- -- -- --
Total Non-Current Assets $14.66M $8.08M $8.27M $11.12M $23.29M $53.46M $90.99M $85.55M $38.17M $41.64M
Total Assets $219.6M $108.9M $64.00M $64.21M $79.59M $151.2M $223.4M $174.4M $178.8M $111.1M
Accounts Payable $7.89M $3.44M $1.86M $1.81M $4.33M $4.70M $3.76M $6.12M $1.88M $3.69M
Short-Term Debt $12.22M $5.93M -- -- -- -- -- -- -- --
Deferred Revenue (Current) -- -- -- -- $296K $296K $296K $296K $2.60M $602K
Other Current Liabilities $2.0K $64K $1.0K $204K $296K -- -- -- -- --
Total Current Liabilities $29.57M $16.59M $13.42M $7.78M $16.62M $41.96M $38.70M $20.35M $5.61M $8.30M
Long-Term Debt $7.81M $13.04M -- -- -- -- -- -- -- --
Deferred Revenue (Non-Current) -- -- -- -- -- -- -- $0 $3.06M $3.66M
Other Non-Current Liabilities -- -- -- -- $200K -- -- -- -- --
Total Non-Current Liabilities $30.78M $48.31M $35.75M $29.67M $20.59M $6.69M $6.25M $20.00M $3.06M $3.66M
Total Liabilities $60.35M $64.90M $49.18M $37.45M $37.22M $48.65M $44.95M $40.35M $8.67M $11.96M
Total Debt (incl. Leases) $24.97M $23.05M $5.40M $7.63M $9.38M $6.97M $7.95M -- -- --
Common Stock $550K $457K $265K $177K $1.47M $961K $836K $479K $469K $403K
Retained Earnings -$742.1M -$813.3M -$749.5M -$695.3M -$655.6M -$570.7M -$486.5M -$410.2M -$359.8M -$332.5M
Accumulated Other Comp. Income $138K $8.0K -$66K -$129K -$27K -$10K -- -- -- --
Total Stockholders' Equity $159.2M $44.03M $14.83M $26.76M $42.37M $102.6M $178.4M $134.0M $170.1M $99.10M
Total Equity $159.2M $44.03M $14.83M $26.76M $42.37M $102.6M $178.4M $134.0M $170.1M $99.10M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $66.28M $56.23M $61.37M $78.44M $82.88M $163.5M $15.94M $23.36M
Short-Term Investments $68.66M $90.60M $106.9M $113.0M $124.2M $61.98M $68.22M $74.36M
Cash & Short-Term Investments $134.9M $146.8M $168.3M $191.4M $207.1M $225.5M $84.50M $98.10M
Accounts Receivable, Net $15.73M $9.39M $6.20M $6.15M -- -- -- --
Inventory $4.66M $5.92M $6.05M $5.49M $4.85M $2.69M -- --
Total Current Assets $157.7M $164.6M $183.0M $204.9M $216.1M $232.3M $88.12M $100.9M
Property, Plant & Equipment, Net $9.49M $10.15M $10.56M $9.92M $10.34M $9.49M $6.95M $4.43M
Other Non-Current Assets $827K $827K $827K $781K $541K $338K $57K $96K
Total Non-Current Assets $14.21M $14.93M $15.51M $14.66M $14.96M $13.97M $11.24M $8.08M
Total Assets $171.9M $179.5M $198.5M $219.6M $231.1M $246.2M $99.36M $108.9M
Accounts Payable $3.41M $2.99M $4.07M $7.89M $5.93M $7.34M $5.02M $3.44M
Short-Term Debt $11.85M $13.33M $13.33M $12.22M $8.89M $5.56M $8.15M $5.93M
Other Current Liabilities -- -- -- $2.0K $35K $80K $317K $64K
Total Current Liabilities $27.71M $24.81M $31.05M $29.57M $22.18M $34.52M $17.98M $16.59M
Long-Term Debt $0 $1.66M $4.75M $7.81M $10.86M $14.01M $11.14M $13.04M
Deferred Revenue (Non-Current) $677K $677K $425K -- -- -- -- --
Total Non-Current Liabilities $18.34M $26.64M $22.51M $30.78M $37.68M $48.14M $39.98M $48.31M
Total Liabilities $46.05M $51.45M $53.55M $60.35M $59.86M $82.66M $57.97M $64.90M
Total Debt (incl. Leases) $16.63M $19.87M $23.17M $24.97M $24.11M $24.08M $23.98M $23.05M
Common Stock $572K $572K $568K $550K $524K $512K $490K $457K
Retained Earnings -$784.1M -$779.3M -$759.1M -$742.1M -$721.6M -$716.5M -$825.3M -$813.3M
Accumulated Other Comp. Income -$229K -$79K -$21K $138K $10K -$45K -$67K $8.0K
Total Stockholders' Equity $125.9M $128.1M $144.9M $159.2M $171.2M $163.6M $41.40M $44.03M
Total Equity $125.9M $128.1M $144.9M $159.2M $171.2M $163.6M $41.40M $44.03M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $71.18M -$63.73M -$54.19M -$39.70M -$84.94M -$84.23M -$76.28M -$56.67M -$27.32M -$21.87M
Depreciation & Amortization $2.55M $2.00M $2.29M $3.09M $3.25M $4.59M $7.82M $2.36M $741K $825K
Stock-Based Compensation $10.78M $6.63M $4.77M $3.05M $8.92M $5.85M $7.34M $8.18M $4.64M $4.83M
Change in Receivables -$6.15M -- -- $3.00M -$3.00M -- $81K $26K $17K -$9.0K
Change in Inventory -$5.49M -- -- -- -- -- -- -- -- --
Change in Payables -- -- -- -- -- -- -- $7.67M -$1.30M $2.82M
Operating Cash Flow -$76.33M -$56.02M -$37.01M -$43.48M -$65.67M -$35.02M -$62.82M -$39.11M -$22.66M -$13.01M
Capital Expenditure -$7.97M -$2.45M -$331K -$130K -$4.15M -$1.34M -$6.31M -$9.24M -$860K -$519K
Free Cash Flow -$84.30M -$58.46M -$37.34M -$43.61M -$69.82M -$36.35M -$69.13M -$48.35M -$23.52M -$13.53M
Purchases of Investments -- -- -- -- -- -- -- -$136.1M $0 $0
Investing Cash Flow $105.0M -$39.24M $208K -$23.96M $66.06M -$83.71M $59.98M -$85.09M -$860K -$519K
Common Stock Issued $17.30M $15.47M $14.41M $12.84M $8.05M -- $16.96M -- -- --
Financing Cash Flow $26.04M $104.1M $37.06M $43.17M $24.86M $1.94M $113.9M $5.48M $92.40M $42.54M
Net Change in Cash $54.74M $8.88M $256K -$24.27M $25.26M -$116.8M $111.1M -$118.7M $68.89M $29.00M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$4.81M -$20.19M -$17.07M -$20.46M -$5.16M $108.8M -$12.03M -$9.29M
Depreciation & Amortization $705K $665K $690K $863K $608K $544K $534K $539K
Stock-Based Compensation $2.79M $3.37M $2.96M $2.56M $2.69M $2.83M $2.70M $1.96M
Change in Receivables -$6.34M -$3.19M -$53K -- -- -- -- --
Change in Inventory $1.26M $133K -$561K -- -- -- -- --
Operating Cash Flow -$8.31M -$17.50M -$19.80M -$17.95M -$21.19M -$18.78M -$18.40M -$16.56M
Capital Expenditure -$219K -$479K -$935K -$1.15M -$2.52M -$2.90M -$1.40M -$606K
Free Cash Flow -$8.53M -$17.98M -$20.74M -$19.11M -$23.71M -$21.68M -$19.80M -$17.16M
Investing Cash Flow $21.70M $15.69M $4.96M $9.55M -$64.63M $155.9M $4.21M $18.88M
Common Stock Issued -- -- -- $0 $0 $10.50M $6.80M $5.51M
Financing Cash Flow -$3.34M -$3.33M -$2.22M $3.61M $5.16M $10.49M $6.77M $5.31M
Net Change in Cash $10.05M -$5.14M -$17.06M -$4.79M -$80.65M $147.6M -$7.42M $7.63M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 73.7% -- -- -- -- -- -- -- -- --
Operating Margin -1536.9% -- -1346.7% -3600.8% -2994.5% -814.2% -- -1940.2% -3325.7% -2686.3%
Net Profit Margin 1223.1% -- -1548.2% -2807.4% -2831.2% -842.3% -- -1890.3% -3263.9% -2460.4%
Return on Equity (ROE) 44.7% -144.7% -365.5% -148.3% -200.5% -82.1% -42.8% -42.3% -16.1% -22.1%
Return on Assets (ROA) 32.4% -58.5% -84.7% -61.8% -106.7% -55.7% -34.1% -32.5% -15.3% -19.7%
Current Ratio 6.93x 6.08x 4.15x 6.83x 3.39x 2.33x 3.42x 4.37x 25.07x 8.37x
Quick Ratio 6.74x 5.91x 3.92x 6.75x 3.24x 2.26x 3.34x 4.18x 24.59x 8.35x
Debt to Equity 0.16x 0.52x 0.36x 0.29x 0.22x 0.07x 0.04x -- -- --
Revenue Growth (YoY) -- -- +147.5% -52.9% -70.0% -- -- +258.2% -5.8% -14.5%
5Y Revenue / Share Growth -95.9% -- -89.6% -64.2% +2829.2% +186.4% -- -98.4% -99.8% -99.4%
10Y Revenue / Share Growth -88.3% -- -99.8% -99.9% -83.4% -- -- -- -- --
5Y Net Income / Share Growth -- -- -- -- -- -- -- -113.5% -- --
10Y Net Income / Share Growth -- -- -101.2% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -49.7% -49.1% 45.6% 44.7% 48.1% 35.0% -106.7% -144.7%
Return on Assets (ROA) -36.4% -35.0% 33.3% 32.4% 35.6% 23.2% -44.5% -58.5%
Current Ratio 5.69x 6.63x 5.89x 6.93x 9.74x 6.73x 4.90x 6.08x
Quick Ratio 5.52x 6.40x 5.70x 6.74x 9.53x 6.65x 4.70x 5.91x
Debt to Equity 0.13x 0.16x 0.16x 0.16x 0.14x 0.15x 0.58x 0.52x
Revenue Growth (YoY) -- +2745.0% -- -- -- -- -- --
Net Income Growth (YoY) -- -118.6% -- -- -- +1369.5% -- --
EPS Growth (YoY) -- -116.9% -- -- -- +989.5% -- --
Source: SEC EDGAR CompanyFacts (CIK 0000318306) · from June 30, 2010 Data through September 30, 2026 · synced Nov 20, 2026, 05:47 UTC · Open in terminal